Are NAD+ supplements (NMN/NR) worth it?
NMN and NR demonstrably raise NAD+ in your blood and appear to be safe, but whether you will actually notice any difference in muscle strength, heart function or memory? That is far from proven in humans. Note too: NR is authorised as a supplement in the EU, NMN is not (yet).
NAD+ is present in every cell of your body and is essential for energy production, DNA repair and the suppression of inflammation. Your levels decline as you age, although that has only been consistently demonstrated in a handful of human studies. What that decline actually causes is known mainly from cell and animal research, and that does not translate straightforwardly to humans1,2.
On one point the human evidence is already fairly solid: if you take NAD precursor supplements (such as NMN or NR), your NAD+ levels measurably rise in blood and multiple tissues. That is the most robust finding from the available human studies. Both supplements are also considered safe and well tolerated in those studies, with no serious side effects2,3,1.
Whether those higher NAD+ levels also produce noticeable health benefits is the big open question. For muscle strength, heart function and cognition, outcomes in human studies have so far been mixed and inconclusive. The studies are too small and too varied in design for firm conclusions2,1,3.
In mouse studies the picture looks more promising. In mice with Alzheimer-like features, NR supplementation reduced brain inflammation, slowed cellular ageing and improved memory4. Positive effects on heart and metabolic disease have also been found in animals, but robust human evidence is still lacking5. Reduced NAD+ levels appear to influence several ageing processes, such as the energy factories in your cells and DNA repair. But again, this has so far been demonstrated in cell and animal research, not in humans6,7,8.
The interim verdict is twofold. NMN and NR do biochemically what they promise and are probably safe at the tested doses. But whether that leads to better health or a longer life in humans has not yet been proven. Bear in mind, too, the legal status: NR is authorised as a novel food in the EU, but NMN is not yet on that list and currently may not be sold as a supplement here (EFSA did judge 300 mg per day to be safe in 2026). The field also relies heavily on animal data that cannot be directly translated, and the human studies are too small to draw clinically meaningful conclusions1,2.
All claims are based on the supplied abstracts (PMID 41083806, 37068054, 37619764, 34497121, 34843394, 37848251, 26785480, 24786309). The human studies are limited in size; most mechanistic evidence comes from cell and animal research.